A strategy for investigating the CYP superfamily using targeted antibodies is a paradigm for functional genomic studies

被引:11
作者
Edwards, RJ [1 ]
Boobis, AR [1 ]
Davies, DS [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Med, Clin Pharmacol Sect, London W12 0NN, England
关键词
D O I
10.1124/dmd.31.12.1476
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this review we describe the use of targeted antibodies developed to facilitate studies on the expression of P450 proteins. The challenge of producing specific antibodies that distinguish between often highly related P450 proteins has led to the development of methods of antibody production to meet this need. Targeting antibodies toward the C terminus of P450 proteins has been found to be a particularly successful approach that is both rapid and efficient at producing specifically binding antibodies. Recent advances in genomic sequencing and proteomics now allow ready identification of expressed proteins. The levels and distributions of these proteins may be determined using antibody-based methods. However, for each protein to be studied, a unique antibody will be required. Consequently, some means of producing large numbers of well defined antibodies is needed. In this context, the potential of extending the approach used to produce specific antibodies against P450 proteins to the wider field of functional genomics is discussed.
引用
收藏
页码:1476 / 1480
页数:5
相关论文
共 34 条
[1]   Specific inhibition of human CYP1A2 using a targeted antibody [J].
Adams, DA ;
Edwards, RJ ;
Davies, DS ;
Boobis, AR .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) :189-197
[2]   Expression and localization of CYP3A4 and CYP3A5 in human lung [J].
Anttila, S ;
Hukkanen, J ;
Hakkola, J ;
Stjernvall, T ;
Beaune, P ;
Edwards, RJ ;
Boobis, AR ;
Pelkonen, O ;
Raunio, H .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (03) :242-249
[3]   Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine [J].
Burk, O ;
Tegude, H ;
Koch, I ;
Hustert, E ;
Wolbold, R ;
Glaeser, H ;
Klein, K ;
Fromm, MF ;
Nuessler, AK ;
Neuhaus, P ;
Zanger, UM ;
Eichelbaum, M ;
Wojnowski, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :24280-24288
[4]  
Conney AH, 1969, MICROSOMES DRUG OXID
[5]   Antibody arrays for high-throughput screening of antibody-antigen interactions [J].
de Wildt, RMT ;
Mundy, CR ;
Gorick, BD ;
Tomlinson, IM .
NATURE BIOTECHNOLOGY, 2000, 18 (09) :989-994
[6]   Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues [J].
Debri, K ;
Boobis, AR ;
Edwards, RJ .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (12) :2047-2056
[7]  
Edwards R J, 1998, Methods Mol Biol, V107, P239
[8]  
EDWARDS RJ, 1991, METHOD ENZYMOL, V206, P220
[9]   Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans [J].
Edwards, RJ ;
Adams, DA ;
Watts, PS ;
Davies, DS ;
Boobis, AR .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (03) :377-387
[10]   SHORT SYNTHETIC PEPTIDES EXPLOITED FOR RELIABLE AND SPECIFIC TARGETING OF ANTIBODIES TO THE C-TERMINI OF CYTOCHROME-P450 ENZYMES [J].
EDWARDS, RJ ;
SINGLETON, AM ;
MURRAY, BP ;
DAVIES, DS ;
BOOBIS, AR .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (01) :39-47